Arcus Biosciences, Inc. (RCUS) stock analysis and AI prediction
The company facts of Arcus Biosciences, Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Arcus Biosciences, Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
- Sector
- Healthcare
- Exchange
- NYSE
- Market value
- $2.3 billion
- Size
- Mid cap
- Employees
- 601
- Headquarters
- HAYWARD, CA
- Listed since
- March 15, 2018
- Website
- arcusbio.com
More Healthcare stocks
Other mid cap stocks
Keep going
RCUS questions
What is the AI prediction for RCUS stock?
Each market day our model rates Arcus Biosciences, Inc. (RCUS) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the RCUS prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for RCUS?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see RCUS options?
The RCUS options page explains its calls, puts and Greeks. The full RCUS options chain, every strike and expiry, is in the OpPreds app.